Nisoldipine increases the bioavailability of endothelial NO

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 364, Issue 2, 2001, Pages 110-116

  Berkels, R ^a   Roesen, R ^a   Bartels, H ^a   Purol Schnabel, S ^a   Kirmiziguel, I ^a   Farmer, Hailey ^b   Born, Gustav V ^b   Klaus, W ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Antioxidative; Calcium antagonist; Endothelium; Nisoldipine; Nitric oxide

Indexed keywords

CALCIUM ANTAGONIST; CALCIUM CHANNEL L TYPE; NISOLDIPINE; NITRIC OXIDE;

ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENANTIOMER; ENDOTHELIUM; ENZYME METABOLISM; HYPERGLYCEMIA; NONHUMAN; RABBIT; RAT;

ANIMALS; BIOLOGICAL AVAILABILITY; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; NISOLDIPINE; NITRIC OXIDE; NITRITES; ORGAN CULTURE TECHNIQUES; RABBITS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SWINE; VASODILATION; VASODILATOR AGENTS;

EID: 0034906045     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002100100429     Document Type: Article

References (57)

1. Ion channels and regulation of intracellular calcium in vascular endothelial cells
2. Measurement of nitric oxide in biological models
3. The calcium modulator nifedipine exerts its antiaggregatory property via a nitric oxide mediated process
4. The calcium antagonist nifedipine stimulates endothelial NO release in therapeutical concentrations
5. i and NO in endothelial cells
6. Dihydropyridine calcium antagonist induced modulation of endothelial function - A review
7. A new method to measure nitrate/nitrite with an NO-sensitive electrode
8. 2+ and nitric oxide in bradykinin-stimulated vascular endothelial cells
9. 2+ channel antagonists
10. Bradykinin-induced increases in cytosolic calcium and ionic currents in cultured bovine aortic endothelial cells
11. Actions of 1,4-dihydropyridines in isolated mesenteric vascular beds
12. Calcium channel blockade enhances nitric oxide synthase expression by cultured endothelial cells
13. Introduction of apoptosis by high proinsulin and glucose in cultured human umbilical vein endothelial cells is mediated by reactive oxygen species
14. Generation of reactive oxygen intermediates, activation of NF-KB, and induction of apoptosis in human endothelial cells by glucose: Role of nitric oxide synthase?
15. Experimental vasoprotection by calcium antagonists against calcium-mediated arteriosclerotic alterations
16. Current status of calcium channel blockers
17. Calcium antagonists and endothelial function: Focus on nitric oxide and endothelin
18. The actions of nifedipine and nisoldipine on the contractile activity of human coronary arteries and human cardiac tissue in vitro
19. Selectivity scale of calcium antagonists in the human cardiovascular system based on in vitro studies
20. 2+/EDRF signaling are due to generation of superoxide anions
21. Nitric oxide (EDRF) enhances the vasorelaxing effect of nitrendipine in various isolated arteries
22. Interaction of 1,4-dihydropyridine calcium channel antagonists with biological membranes: Lipid bilayer partitioning could occur before drug binding to receptors
23. Free radicals in disease
24. Nitric oxide availability in diabetes mellitus
25. Antiperoxidant effects of dihydropyridine calcium antagonists
26. Endothelium-derived hyperpolarizing factor, but not nitric oxide or prostacyclin release, is resistant to menadione-induced oxidative stress in the bovine coronary artery
27. Influence of nifedipine on experimental arteriosclerosis
28. Reduced responses of nitrendipine in PGF2 alpha-precontracted porcine isolated arteries after pretreatment with methylene blue
29. The influence of endothelium on the action of PGF2 alpha and some dihydropyridine-type calcium antagonists in porcine basilar arteries
30. Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT)
31. The antioxidative effect of carboxyfullerenes (C3/D3) on iron-induced oxidative injury in CNS
32. Reduction of endothelin levels by the dihydropyridine calcium antagonist nisoldipine and a 'natural factor' in cultured human endothelial cells
33. In vitro antioxidant activity of calcium antagonists against LDL oxidation compared with alpha-tocopherol
34. Comparative antioxidant activities of propranolol, nifedipine, verapamil, and diltiazem against sarcolemmal membrane lipid peroxidation
35. Antioxidant activity of calcium channel blocking drugs
36. Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor
37. 1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats
38. Role of oxygen derived radicals for vascular dysfunction in the diabetic heart: Prevention by alpha-tocopherol?
39. In vitro effects of two novel calcium antagonists (nitrendipine and nisoldipine) on intraplatelet calcium redistribution, platelet aggregation and thromboxanc A2 formation. Comparison with diltiazem, nifedipine and verapamil
40. The effect of the calcium-antagonist nitrendipine on intracellu-lar calcium concentration in endothelial cells
41. Facilitation of the vasorelaxant action of calcium antagonists by basal nitric oxide in depolarized artery
42. Effect of Trolox, a synthetic analog of alpha-tocopherol, on cytotoxicity induced by UV irradiation and antioxidants
43. Reaction of peroxy nitrite with oxyhaemoglobin: Interference with photometrical determination of nitric oxide
44. Type 2 diabetes and large vessel disease
45. The influence of calcium channel blockers on superoxide anions
46. Antioxi-dant effect of drugs used in cardiovascular therapy
47. Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production
48. Chemiluminescent detection of oxidants in vascular tissue, lucigenin but not coelenterazine enhances superoxide formation
49. Free radicals mediate endothelial cell dysfunction caused by elevated glucose
50. Calcium channels: Mechanisms of selectivity, permeation, and block
51. Continuous monitoring of nitric oxide release from human umbilical vein endothelial cells
52. Nifedipine improves endothelial function in hypercholesterolemia, independently of an effect on blood pressure or plasma lipids
53. The calcium channel antagonist S 11568 causes endothelium-dependent relaxation in canine arteries
54. A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis
55. Beta-blockers, calcium channel blockers and the sulfhydryl-ACE inhibitors demonstrate protection against free-radical-mediated injury of cardiovascular cells and membranes
56. Effects of nisoldipine upon endothelial dysfunction following ischaemic and peroxidative injury in the perfused rat heart
57. Amlodipine releases nitric oxide from canine coronary microvessels: An unexpected mechanism of action of a calcium channel-blocking agent